Lee Rivas - R1 RCM CEO Director

RCM Stock  USD 14.31  0.01  0.07%   

CEO

Lee Rivas is CEO Director of R1 RCM Inc
Age 49
Address 434 W. Ascension Way, Murray, UT, United States, 84123
Phone312-324-7820
Webhttps://www.r1rcm.com

R1 RCM Management Efficiency

The company has Return on Asset of 0.0235 % which means that on every $100 spent on assets, it made $0.0235 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.022) %, meaning that it generated no profit with money invested by stockholders. R1 RCM's management efficiency ratios could be used to measure how well R1 RCM manages its routine affairs as well as how well it operates its assets and liabilities. As of the 21st of November 2024, Return On Equity is likely to grow to 0, while Return On Tangible Assets are likely to drop 0. At this time, R1 RCM's Intangibles To Total Assets are very stable compared to the past year. As of the 21st of November 2024, Debt To Assets is likely to grow to 0.46, while Other Assets are likely to drop about 113.3 M.
R1 RCM Inc has 1.74 B in debt with debt to equity (D/E) ratio of 0.69, which is OK given its current industry classification. R1 RCM Inc has a current ratio of 1.53, which is typical for the industry and considered as normal. Note however, debt could still be an excellent tool for RCM to invest in growth at high rates of return.

Similar Executives

Found 6 records

CEO Age

Seth BlackleyEvolent Health
45
Dan McCarthyEvolent Health
39
Michael HaysNational Research Corp
69
Parth MehrotraPrivia Health Group
45
Kevin CoopDefinitive Healthcare Corp
59
Jon KesslerHealthEquity
56
R1 RCM Inc. provides technology-driven solutions that transform the patient experience and financial performance of hospitals, health systems, and medical groups. The company was founded in 2003 and is headquartered in Murray, Utah. R1 Rcm operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 20800 people. R1 RCM Inc (RCM) is traded on NASDAQ Exchange in USA. It is located in 434 W. Ascension Way, Murray, UT, United States, 84123 and employs 29,400 people. R1 RCM is listed under Health Care Providers & Services category by Fama And French industry classification.

Management Performance

R1 RCM Inc Leadership Team

Elected by the shareholders, the R1 RCM's board of directors comprises two types of representatives: R1 RCM inside directors who are chosen from within the company, and outside directors, selected externally and held independent of RCM. The board's role is to monitor R1 RCM's management team and ensure that shareholders' interests are well served. R1 RCM's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, R1 RCM's outside directors are responsible for providing unbiased perspectives on the board's policies.
Sean Radcliffe, General VP
Pamela Spikner, Principal Officer
Atif Rahim, Sr Devel
Brian Gambs, EVP Officer
Joseph Flanagan, President CEO, Director
Kate Sanderson, Executive Officer
Evan CFA, Senior Relations
David Strickle, Executive Integration
Jennifer Williams, CFO VP
Gary Long, Executive Vice President Chief Commercial Officer
Jay Sreedharan, Chief Officer
Lee Rivas, CEO Director
Richard Evans, Corporate VP
Sean JD, General VP
Kyle Hicok, Executive Officer
Logan Johnston, Executive Management
Rachel Wilson, CFO VP
John Sparby, President
Corey Perman, Executive Risk

RCM Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is R1 RCM a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether R1 RCM Inc is a strong investment it is important to analyze R1 RCM's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact R1 RCM's future performance. For an informed investment choice regarding RCM Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in R1 RCM Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of R1 RCM. If investors know RCM will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about R1 RCM listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.99)
Earnings Share
(0.14)
Revenue Per Share
5.854
Quarterly Revenue Growth
0.147
Return On Assets
0.0235
The market value of R1 RCM Inc is measured differently than its book value, which is the value of RCM that is recorded on the company's balance sheet. Investors also form their own opinion of R1 RCM's value that differs from its market value or its book value, called intrinsic value, which is R1 RCM's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because R1 RCM's market value can be influenced by many factors that don't directly affect R1 RCM's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between R1 RCM's value and its price as these two are different measures arrived at by different means. Investors typically determine if R1 RCM is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, R1 RCM's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.